CC
CAI icon

Courier Capital’s Caris Life Sciences CAI Stock Holding History

Courier Capital’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-24,000
Closed -$428K – 395
2026
Q2 		$428K Buy
24,000
+5,000
+26% +$89.5K 0.02% 309
2026
Q1 		$340K Buy
19,000
+10,450
+122% +$228K 0.02% 319
2025
Q4 		$231K Buy
+8,550
New +$241K 0.01% 352

Other funds holding CAI

ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
CCAL
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return
RF
Roxbury Financial Mount Arlington, New Jersey $130M AUM 20.04% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

Courier Capital's CAI Position: Q3 2026 in Review

Courier Capital sold out of Caris Life Sciences (CAI) in Q3 2026, closing a stake of 24,000 shares — an estimated $428K sold.

Courier Capital first reported a position in CAI in Q4 2025 and held it in 3 quarters. The position peaked at $428K in Q2 2026. 17 funds tracked by Wall St. Rank hold CAI as of Q3 2026.

  • Courier Capital reported no remaining Caris Life Sciences position as of Q3 2026 after selling out during the quarter.
  • Courier Capital sold 24,000 Caris Life Sciences shares in Q3 2026, an estimated $428K.
  • Courier Capital first reported a position in Caris Life Sciences in Q4 2025 and held it in 3 quarters.
  • Courier Capital's Caris Life Sciences position peaked at $428K in Q2 2026.
  • 17 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.

Based on Courier Capital's 13F filing for Q3 2026, filed 13 Oct 2026.